Neutral
Milestone Pharmaceuticals (MIST) investors approve equity plan, elect board and ratify PwC
Milestone Pharmaceuticals shareholders approved an amendment to its 2019 Equity Incentive Plan, increasing authorized ordinary shares by 6,800,000 for...